Tuesday, 17 November 2026 X LinkedIn Bluesky RSS Send us news
LungDaily The Pulse of Respiratory Health
World COPD Day is on Wednesday 18 November · #WorldCOPDDay Our coverage →
New Paper Alert

ANCHOR-RA study presented at ACR26 examines clinical clues for RA-ILD screening

Dr Jeffrey Sparks presented ANCHOR-RA, a prospective cross-sectional study of risk factors for interstitial lung disease in at-risk patients with rheumatoid arthritis, according to Dr John Cush.

“Which of our RA patients will develop RA-ILD, and how can we better identify these patients?”— Dr. John Cush

Dr John Cush wrote on X that Dr Jeffrey Sparks presented findings from the ANCHOR-RA trial in abstract #2884 at #ACR26. The post is headed "Looking for RA-ILD: 9 Clinical Clues from ANCHOR-RA".

According to Cush's post, ANCHOR-RA is a large prospective cross-sectional study evaluating risk factors for interstitial lung disease (ILD) in at-risk patients with rheumatoid arthritis (RA) who have no known ILD diagnosis. The stated goal was to identify clinical characteristics that can guide screening for RA-ILD.

The post asks which patients with RA will develop RA-ILD and how such patients can be better identified. The text provided does not list the nine clues or report any results. No journal publication is cited, and the findings were presented as a conference abstract.

Original source

#ild#screening#trial#diagnostics

Related stories

More in New Paper Alert

See all

LungDaily reports on public posts, papers and news from the lung health community. This article is based on the source linked above and was produced with AI-assisted tools under our editorial standards; facts and quotes are checked against the original before publication. Featured here, or spotted an error? Request a correction or removal.